Cargando…

Human Immunodeficiency Virus gag and protease: partners in resistance

Human Immunodeficiency Virus (HIV) maturation plays an essential role in the viral life cycle by enabling the generation of mature infectious virus particles through proteolytic processing of the viral Gag and GagPol precursor proteins. An impaired polyprotein processing results in the production of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fun, Axel, Wensing, Annemarie MJ, Verheyen, Jens, Nijhuis, Monique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422997/ https://www.ncbi.nlm.nih.gov/pubmed/22867298 http://dx.doi.org/10.1186/1742-4690-9-63

Ejemplares similares

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity
por: van Maarseveen, Noortje M, et al.
Publicado: (2012)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses
por: Marije Hofstra, Laura, et al.
Publicado: (2014)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis
por: Messiaen, Peter, et al.
Publicado: (2013)

Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection
por: Hermans, Lucas E, et al.
Publicado: (2022)

Properties and Functions of Feline Immunodeficiency Virus Gag Domains in Virion Assembly and Budding
por: González, Silvia A., et al.
Publicado: (2018)

Review and Perspectives on the Structure–Function Relationships of the Gag Subunits of Feline Immunodeficiency Virus
por: Long, Mathieu, et al.
Publicado: (2021)

Kunjin replicon-based simian immunodeficiency virus gag vaccines
por: Anraku, Itaru, et al.
Publicado: (2008)

Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates
por: Pettit, Steve C, et al.
Publicado: (2005)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
por: Fun, Axel, et al.
Publicado: (2011)

Diminished transmission of drug resistant HIV-1 variants with reduced replication capacity in a human transmission model
por: Pingen, Marieke, et al.
Publicado: (2014)

Structural characterization of membrane-bound human immunodeficiency virus-1 Gag matrix with neutron reflectometry
por: Eells, Rebecca, et al.
Publicado: (2017)

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel
por: Günthard, Huldrych F, et al.
Publicado: (2019)

Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae
por: Tomo, Naoki, et al.
Publicado: (2013)

Identification and analysis of the gag-pol ribosomal frameshift site of feline immunodeficiency virus
por: Morikawa, Shigeru, et al.
Publicado: (1992)

In Vitro Analysis of Human Immunodeficiency Virus Particle Dissociation: Gag Proteolytic Processing Influences Dissociation Kinetics
por: Müller, Barbara, et al.
Publicado: (2014)

HIV-1 Gag C-terminal amino acid substitutions emerging under selective pressure of protease inhibitors in patient populations infected with different HIV-1 subtypes
por: Li, Guangdi, et al.
Publicado: (2014)

Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance
por: Fun, Axel, et al.
Publicado: (2018)

RNA secondary structure of the feline immunodeficiency virus 5′UTR and Gag coding region
por: James, Laurie, et al.
Publicado: (2008)

Deep Sequencing of Protease Inhibitor Resistant HIV Patient Isolates Reveals Patterns of Correlated Mutations in Gag and Protease
por: Flynn, William F., et al.
Publicado: (2015)

The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies
por: Sato, Akinori
Publicado: (2015)

Functional conservation of HIV-1 Gag: implications for rational drug design
por: Li, Guangdi, et al.
Publicado: (2013)

Factors Associated With Poor Linkage to Human Immunodeficiency Virus Care Among Index Clients and Sex Partners Receiving Human Immunodeficiency Virus Assisted Partner Services in Kenya
por: Wamuti, Beatrice, et al.
Publicado: (2020)

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
por: Fuchs, Jonathan D., et al.
Publicado: (2015)

The Initial Step in Human Immunodeficiency Virus Type 1 GagProPol Processing Can Be Regulated by Reversible Oxidation
por: Daniels, Sarah I., et al.
Publicado: (2010)

Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants
por: Quirk, Erin K., et al.
Publicado: (2014)

Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner
por: Alford, Justine E., et al.
Publicado: (2016)

Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses
por: Lawrence, Tessa M., et al.
Publicado: (2013)

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
por: Sutherland, Katherine A., et al.
Publicado: (2015)

Acceptance of referral for partners by clients testing positive for human immunodeficiency virus
por: Netsanet, Fetene, et al.
Publicado: (2013)

Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites
por: Kraus, Benjamin, et al.
Publicado: (2011)

Lentiviral Gag Assembly Analyzed through the Functional Characterization of Chimeric Simian Immunodeficiency Viruses Expressing Different Domains of the Feline Immunodeficiency Virus Capsid Protein
por: Esteva, María J., et al.
Publicado: (2014)

Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
por: Codoñer, Francisco M, et al.
Publicado: (2017)

Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach
por: Dayer, Mohammad Reza, et al.
Publicado: (2014)

Gag-Pol Transframe Domain p6* Is Essential for HIV-1 Protease-Mediated Virus Maturation
por: Yu, Fu-Hsien, et al.
Publicado: (2015)

Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor–Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis
por: Bertagnolio, Silvia, et al.
Publicado: (2020)

Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV
por: Climaco-Arvizu, Samantha, et al.
Publicado: (2022)

Partner Notification Approaches for Sex Partners and Children of Human Immunodeficiency Virus Index Cases in Côte d'Ivoire
por: Kingbo, Marie-Huguette K.A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5o61bi3b660s0kgagkpdr6sa6a